MDxHealth SA

Patent Applications and Registrations

Patent applications and USPTO patent grants for MDxHealth SA.The latest application filed is for "mgmt epigenetic deep-sequencing assay".

Company Profile

4.16.20

MDxHealth SA - Herstal BE
MDXHEALTH SA - Sart-Tilman Liege
MDxHealth S.A. - Herstal N/A BE
MDxHealth SA - Sart-Tilman N/A BE
MDxHealth SA - BE BE
MDxHEALTH SA -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Mgmt Epigenetic Deep-sequencing Assay App 20200010907 - Trooskens; Geert ; et al.	2020-01-09
Method For Predicting And Treating Clinically Significant Prostate Cancer App 20190211405 - Hessels; Daphne ; et al.	2019-07-11
Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples Grant 10,119,166 - Van Criekinge November 6, 2	2018-11-06
Method for determining the methylation status of the promoter region of the TWIST1 gene in genomic DNA from bladder cells Grant 10,113,202 - Renard , et al. October 30, 2	2018-10-30
Methylation detection of the MGMT promoter Grant 10,053,724 - Vlassenbroeck , et al. August 21, 2	2018-08-21
Methylation of the EPB41L3 gene or the promoter of the EPB41L3 gene in a test sample comprising cervical cells Grant 10,041,128 - Van Criekinge , et al. August 7, 2	2018-08-07
Methods of detecting mutations in BRAF and epigenetic changes Grant 9,605,312 - Van Criekinge , et al. March 28, 2	2017-03-28
Methylation of the EPB41L3 Gene or the Promoter of the EPB41L3 Gene in a Test Sample Comprising Cervical Cells App 20160333423 - Van Criekinge; Wim ; et al.	2016-11-17
Method for Determining the Methylation Status of the Promoter Region of the TWIST1 Gene in Genomic DNA from Bladder Cells App 20160208341 - Renard; Isabelle ; et al.	2016-07-21
Methylation of the GATA4 gene in urine samples as a marker for bladder cancer detection Grant 9,388,471 - Louwagie July 12, 2	2016-07-12
Systems, Kits, and Tests for Detecting Colorectal Cancer App 20160194723 - Louwagie; Joost	2016-07-07
Detection and prognosis of cervical cancer Grant 9,371,569 - Van Criekinge , et al. June 21, 2	2016-06-21
Methods for determining methylation of the TWIST1 gene for bladder cancer detection Grant 9,322,065 - Renard , et al. April 26, 2	2016-04-26
Methylation Detection App 20160032368 - Vlassenbroeck; Ilse ; et al.	2016-02-04
Methylation Markers Predictive For Drug Response App 20150292026 - Meijer; Gerrit A. ; et al.	2015-10-15
Methods for Detecting Epigenetic Modifications App 20150240318 - Van Engeland; Manon ; et al.	2015-08-27
Methylation detection of MGMT Grant 9,050,280 - Vlassenbroeck , et al. June 9, 2	2015-06-09
Methods for detecting epigenetic modifications Grant 8,969,046 - Van Engeland , et al. March 3, 2	2015-03-03
Methods of Detecting Mutations and Epigenetic Changes App 20140322714 - Van Criekinge; Wim ; et al.	2014-10-30
Detection Of Mage-a Expression App 20130302363 - Vlassenbroeck; Ilse ; et al.	2013-11-14
Detection of mage-A expression Grant 8,481,700 - Vlassenbroeck , et al. July 9, 2	2013-07-09
Methods Of Detecting Colorectal Cancer App 20120164238 - Joost; Louwagie	2012-06-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.